LeadingBiotech: Cancer Advance is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Gaurav Singal, M.D.
Chief Data Officer at Foundation Medicine

Profile

Gaurav Singal, MD, was named Chief Data Officer of Foundation Medicine in February, 2019. Since joining the company in 2013, Dr. Singal and his team have architected and launched technology and data-centric products that have accelerated patient access to therapy and positioned Foundation Medicine as a leader in molecular information in cancer care. 

Dr. Singal is a physician and computer scientist who initially joined Foundation Medicine to lead an innovation unit focused on new software and data products. To accelerate the vision of bringing real world data to point of care providers, Dr. Singal and his team developed collaborative relationships with clinical data companies, including Flatiron Health. Under Dr. Singal’s leadership, these partnerships have led to the development of the Foundation Medicine-Flatiron Clinico-genomic Database (CGDB), a best-in-class dataset linking genomic information to real-world clinical data which is helping advance personalized healthcare with both biopharma and clinical partners. In addition, Dr. Singal and his team have developed and launched FoundationInsights™, our cloud-based platform for genomic data analysis and visualization, and SmartTrials™, a program that leverages our dataset to help patients access molecularly targeted medicines through clinical trials. These platforms and services have delivered unparalleled value by enabling our partners to accelerate the delivery of novel, personalized therapies to patients.

Prior to Foundation Medicine, Dr. Singal led the development of several natural-language processing (NLP)-based applications to improve efficiency in healthcare delivery and research at Massachusetts General Hospital. His NLP research platform, SoothSayer, has been the basis for several scientific presentations and publications. He received his BS, summa cum laude, in computer engineering with a focus on AI and machine learning from Columbia University, earned an MD with honors from the Harvard-MIT division of Health Sciences and Technology, and completed residency training in Internal Medicine at Massachusetts General Hospital. He continues to see patients as an attending physician at Brigham and Women’s Hospital in Boston, and co-directs a graduate course on health technology and innovation as a member the Harvard Medical School faculty.

Agenda Sessions

  • The Evolving Role of Biomarkers & Diagnostics

    1:30pm